Productivity Loss and Health-Related Quality of Life Among People Living With Alopecia Areata: A Canada-Wide Cross-Sectional Study
Journal of Cutaneous Medicine and Surgery · 03.05.2026
DOI: 10.1177/12034754261445858 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 03.05.2026. Verfasst von Alexander Tam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advancing Health Outcomes, Providence Research, Vancouver, BC, Canada. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer Canada.
Abstract (Originalsprache)
Background
Alopecia areata (AA) is associated with reduced health-related quality of life (HRQOL), and patients with AA also experience psychosocial symptoms that can influence their participation in activities, including work.
Objective
To describe work productivity loss and HRQOL in AA.
Methods
In this cross-sectional study, we administered a web-based questionnaire to adults self-reporting AA recruited from a patient organization. AA severity was assessed using the 6-domain Alopecia and Areata Patient Priority Outcomes Questionnaire, productivity loss was evaluated using the Valuation of Lost Productivity Questionnaire and the Work Productivity and Activity Impairment Questionnaire, and HRQOL was assessed using the Veterans-Rand 12 Questionnaire. Linear regression was used to measure the association between AA severity and the outcomes.
Results
Our final sample of 51 participants was predominantly women (n = 46), White race (n = 37), and working (n = 36). Unadjusted regressions showed that a 1-point increase in the emotional symptoms (ES) domain or activity limitations (AL) domain from AA was associated with increased total productivity loss (49.7 hours [95% CI: 11.5-87.9] and 40.4 hours [4.5-76.4]), paid productivity loss (33.8 hours [3.8-63.8] and 40.7 hours [16.1-65.3]), and worse HRQOL (−0.094 [−0.164 to −0.025] and −0.087 [−0.152 to −0.022]). Percentages of work impairment and activity impairment also increased with higher ES and AL.
Conclusions
Greater ES and AL due to AA were associated with greater impairment in participants’ regular activities in our small sample. Further research is needed in a larger, more representative sample of working adults with AA to elucidate findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Advancing Health Outcomes, Providence Research, Vancouver, BC, Canada.
- Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
- Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
- School of Occupational and Public Health, Faculty of Community Services, Toronto Metropolitan University, ON, Canada.
- Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA, USA.
- Department of Dermatology and Skin Science, The University of British Columbia, Vancouver, BC, Canada.
ORCID-Profile: Alexander Tam
Förderung
- Pfizer Canada
Zitieren
APA
Tam, A., Naik, H., Gilding, A. J., Trenaman, L., Khosravi-Hafshejani, T., Lynd, L. D., & Zhang, W. (2026). Productivity Loss and Health-Related Quality of Life Among People Living With Alopecia Areata: A Canada-Wide Cross-Sectional Study. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754261445858
Vancouver
Tam A, Naik H, Gilding AJ, Trenaman L, Khosravi-Hafshejani T, Lynd LD, et al. Productivity Loss and Health-Related Quality of Life Among People Living With Alopecia Areata: A Canada-Wide Cross-Sectional Study. Journal of Cutaneous Medicine and Surgery. 2026. doi:10.1177/12034754261445858
BibTeX
@article{Tam2026,
author = {Tam, Alexander and Naik, Hiten and Gilding, Anthony J and Trenaman, Logan and Khosravi-Hafshejani, Touraj and Lynd, Larry D and Zhang, Wei},
title = {Productivity Loss and Health-Related Quality of Life Among People Living With Alopecia Areata: A Canada-Wide Cross-Sectional Study},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2026},
doi = {10.1177/12034754261445858}
}
EUVIMED